In the advanced stages of cancer expression levels of soluble PD-L1 are increased that can be detected in circulation thus, cancer-derived exosomal PD-L1 can serve as cancer predicting biomarker (Figure 6A) (Shimada et al., 2021). This evidence concerns the gene CD274 and cancer.